Lipid replacement therapy: A nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function

Cancer and Metastasis Reviews

Volumn 29, Issue 3, 2010, Pages 543-552

  Nicolson, Garth L ^a  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Alkylating agents; Antioxidants; Coenzyme Q10; Electron transport chain; Fatigue; Lipid peroxidation; Membrane lipids; Membranes; Mitochondria; Oxidative stress

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CAMPTOTHECIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ERYTHROPOIETIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; FOLINIC ACID; MEMBRANE LIPID; METHOTREXATE; METHYLPHENIDATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; NTFACTOR; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PLATINUM; PROPAX; REACTIVE OXYGEN METABOLITE; TAXANE DERIVATIVE; UBIDECARENONE; UNCLASSIFIED DRUG; VINCA ALKALOID;

AGING; ANEMIA; CACHEXIA; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOMYOPATHY; CARDIOTOXICITY; CELL FUNCTION; CHRONIC FATIGUE SYNDROME; COLON CANCER; CONGESTIVE HEART FAILURE; CONSTIPATION; DEPRESSION; DIARRHEA; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ABSORPTION; ELECTRON TRANSPORT; HEADACHE; HEART FUNCTION; HEART MITOCHONDRION; HEART RATE; HUMAN; INFECTION; INSOMNIA; LIPID REPLACEMENT THERAPY; LIVER TOXICITY; LUNG CANCER; LUNG FIBROSIS; MALAISE; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RASH; RECTUM CANCER; REVIEW; SIDE EFFECT; SLEEP DISORDER; SUBSTITUTION THERAPY; VOMITING;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FATIGUE; HUMANS; LIPIDS; MITOCHONDRIA; NEOPLASMS; OXIDATIVE STRESS;

EID: 77957582038     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-010-9245-0     Document Type: Review

References (129)

1. M Hofman JL Ryan CD Figueroa-Moseley, et al. 2007 Cancer-related fatigue: The scale of the problem The Oncologist 12 4 10 17573451 10.1634/theoncologist. 12-S1-4
2. LF Brown K Kroenke 2009 Cancer-related fatigue and its association with depression and anxiety: A systematic review Psychosomatics 50 440 447 19855028 10.1176/appi.psy.50.5.440
3. G Prue J Rankin J Allen, et al. 2006 Cancer-related fatigue: A critical appraisal European Journal of Cancer 42 846 863 1:STN:280:DC%2BD283lslKgsw%3D%3D 16460928 10.1016/j.ejca.2005.11.026
4. GA Curt W Breitbart D Cella, et al. 2000 Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition The Oncologist 5 353 360 1:STN:280:DC%2BD3crgtFWnug%3D%3D 11040270 10.1634/theoncologist.5-5-353
5. D Respini PB Jacobsen C Thors, et al. 2003 The prevalence and correlates of fatigue in older cancer patients Critical Reviews in Oncology/Hematology 47 273 279 12962901 10.1016/S1040-8428(02)00176-2 (Pubitemid 37072118)
6. A Sood TJ Moynihan 2005 Cancer-related fatigue: An update Current Oncology Reports 7 277 282 15946587 10.1007/s11912-005-0051-8
7. LM Arnold 2008 Understanding fatigue in major depressive disorder and other medical disorders Psychosomatics 49 185 190 18448771 10.1176/appi.psy.49. 3.185 (Pubitemid 351668718)
8. CM Bender SJ Engberg HS Donovan, et al. 2008 Symptom clusters in adults with chronic health problems and cancer as a comorbidity Oncology Nursing Forum 35 E1 E11 18192145 10.1188/08.ONF.E1-E11
9. EMA Smets B Garssen A Cull, et al. 1996 Applications of the Multidimensional Fatigue Inventory (MFI-20) in cancer patients receiving radiotherapy British Journal of Cancer 73 241 245 1:STN:280:DyaK287ltVWnuw%3D%3D 8546913
10. P Stone J Hardy R Huddart, et al. 2000 Fatigue in patients with prostate cancer receiving hormone therapy European Journal of Cancer 36 1134 1141 1:CAS:528:DC%2BD3cXjvFGqs78%3D 10854947 10.1016/S0959-8049(00)00084-8 (Pubitemid 30330912)
11. D Cella K Davis W Breitbart, et al. 2001 Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors Journal of Clinical Oncology 19 3385 3391 1:STN:280: DC%2BD3MvgtlKntA%3D%3D 11454886
12. K Ahlberg T Ekman F Gaston-Johansson V Mock 2003 Assessment and management of cancer-related fatigue in adults The Lancet 362 9384 640 650 10.1016/S0140-6736(03)14186-4 (Pubitemid 37013308)
13. HB Gutstein 2001 The biological basis for fatigue Cancer 92 1678 1683
14. EF Manzullo CP Escalante 2002 Research into fatigue Hematology/Oncology Clinics of North America 16 619 628 12170571 10.1016/S0889-8588(02)00012-6 (Pubitemid 34827371)
15. B Given C Given F Azzouz M Stommel 2001 Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment Nursing Research 50 222 232 1:STN:280:DC%2BD3MvjtlCmsA%3D%3D 11480531 10.1097/00006199-200107000-00006
16. N Vogelzang W Breitbart D Cella, et al. 1997 Patient caregiver and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey Seminars in Hematology 34 Suppl 2 4 12 1:STN:280: DyaK2szpsl2gsw%3D%3D 9253778
17. L Liu MR Marler BA Parker, et al. 2005 The relationship between fatigue and light exposure during chemotherapy Supportive Care in Cancer 13 1010 1017 15864659 10.1007/s00520-005-0824-5 (Pubitemid 41636009)
18. GR Marrow 2007 Cancer-related fatigue: Causes, consequences and management The Oncologist 12 suppl 1 1 3 10.1634/theoncologist.12-S1-1
19. JD Morrison 1980 Fatigue as a presenting complaint in family practice The Journal of Family Practice 10 795 801 1:STN:280:DyaL3c3ivFehuw%3D%3D 7391758
20. K Kroenke DR Wood AD Mangelsdorff, et al. 1988 Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome JAMA 260 929 934 1:STN:280:DyaL1c3os12luw%3D%3D 3398197 10.1001/jama.260.7.929
21. E McDonald AS David AJ Pelosi AH Mann 1993 Chronic fatigue in primary care attendees Psychological Medicine 23 987 998 1:STN:280:DyaK2c7otFOhsA%3D%3D 8134522 10.1017/S0033291700026453
22. JP Kehrer 1993 Free radicals and mediators of tissue injury and disease Critical Reviews in Toxicology 23 21 48 1:CAS:528:DyaK3sXktVams78%3D 8471159 10.3109/10408449309104073
23. B Halliwell 1996 Oxidative stress, nutrition and health Free Radical Research 25 57 74 1:CAS:528:DyaK28XkvVOht7Y%3D 8814444 10.3109/10715769609145656
24. D Dreher AF Junod 1996 Role of oxygen free radicals in cancer development European Journal of Cancer 32A 30 38 1:CAS:528:DyaK28XitlKqsbo%3D 8695238 10.1016/0959-8049(95)00531-5 (Pubitemid 26086324)
25. S Abidi A Ali 1999 Role of oxygen free radicals in the pathogenesis and etiology of cancer Cancer Letters 142 1 9 10.1016/S0304-3835(99)00112-3 (Pubitemid 29281560)
26. E Stadtman 2002 Introduction to serial reviews on oxidatively modified proteins in aging and disease Free Radical Biology & Medicine 32 789 1:CAS:528:DC%2BD38XjtVeju74%3D 10.1016/S0891-5849(02)00764-5 (Pubitemid 34439248)
27. LJ Marnett 2000 Oxyradicals and DNA damage Carcinogenesis 21 361 370 1:CAS:528:DC%2BD3cXitVeju7c%3D 10688856 10.1093/carcin/21.3.361
28. H Bartsch J Nair 2004 Oxidative stress and lipid peroxidation-driven DNA-lesions in inflammation driven carcinogenesis Cancer Detection and Prevention 28 385 391 1:CAS:528:DC%2BD2MXhtVCgsbo%3D 15582261 10.1016/j.cdp.2004.07.004 (Pubitemid 39568933)
29. L Castro BA Freeman 2001 Reactive oxygen species in human health and disease Nutrition 17 295 307 10.1016/S0899-9007(00)00570-0 (Pubitemid 32178295)
30. TM Johnson ZX Yu VJ Ferrans, et al. 1996 Reactive oxygen species are downstream mediators of p53-dependent apoptosis Proceedings of the National Academy of Science USA 93 11848 11852 1:CAS:528:DyaK28Xmtlamtrc%3D 10.1073/pnas.93.21.11848 (Pubitemid 26347212)
31. S Ghaffari 2008 Oxidative stress in the regulation of normal and neoplastic hematopoiesis Antioxidation and Redox Signaling 10 1923 1940 1:CAS:528:DC%2BD1cXhtVymsbrF 10.1089/ars.2008.2142
32. M Maes 2009 Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms Current Opinions in Psychiatry 22 75 83 10.1097/YCO.0b013e32831a4728
33. M Maes FN Twisk 2009 Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: Disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS Neuro Endocrinology Letters 30 677 693 20038921
34. DA Barber SR Harris 1994 Oxygen free radicals and antioxidants: A review American Pharmacology 34 26 35
35. Y Sun 1990 Free radicals, antioxidant enzymes and carcinogenesis Free Radical Biology & Medicine 8 583 599 1:CAS:528:DyaK3MXkvVKrsLk%3D 10.1016/0891-5849(90)90156-D (Pubitemid 20204421)
36. I Fridovich 1995 Superoxide radical and superoxide dismutases Annual Review of Biochemistry 64 97 112 1:CAS:528:DyaK2MXmsl2qsLs%3D 7574505 10.1146/annurev.bi.64.070195.000525
37. HE Seifried SS McDonald DE Anderson, et al. 2003 The antioxidant conundrum in cancer Cancer Research 61 4295 4298
38. GC Jagetia GK Rajanikant SK Rao, et al. 2003 Alteration in the glutathione, glutathione peroxidase, superoxide dismutase and lipid peroxidation by ascorbic acid in the skin of mice exposed to fractionated gamma radiation Clinica Chimica Acta 332 111 121 10.1016/S0009-8981(03)00132-3 1:CAS:528:DC%2BD3sXjvV2mtrg%3D (Pubitemid 36577497)
39. JL Schwartz 1996 The dual roles of nutrients as antioxidants and prooxidants: Their effects on tumor cell growth The Journal of Nutrition 126 1221S 1227S 1:CAS:528:DyaK28XhvFansbk%3D 8642460
40. R Aeschbach J Loliger BC Scott, et al. 1994 Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol Food Chemistry and Toxicology 32 31 36 1:CAS:528:DyaK2cXis1ymtLg%3D 10.1016/0278-6915(84)90033-4 (Pubitemid 24131117)
41. T Tanaka 1994 Cancer chemoprevention by natural products Oncology Reports 1 1139 1155
42. KN Prasad WC Cole B Kumar, et al. 2001 Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies Journal of the American College of Nutrition 20 450S 453S 1:CAS:528:DC%2BD3MXnvVCisr0%3D 11603656
43. S Toyokuni K Okamoto J Yodio, et al. 1995 Persistent oxidative stress in cancer FEBS Letters 358 1 3 1:CAS:528:DyaK2MXjsFanur4%3D 7821417 10.1016/0014-5793(94)01368-B
44. G Ray S Batra NK Shukla, et al. 2000 Lipid peroxidation, free radical production and antioxidant status in breast cancer Breast Cancer Research and Treatment 59 163 170 1:CAS:528:DC%2BD3cXjslWitrw%3D 10817351 10.1023/A:1006357330486 (Pubitemid 30216139)
45. NS Brown R Bicknell 2001 Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer Breast Cancer Research 3 323 327 1:CAS:528:DC%2BD3MXntlegsLk%3D 11597322 10.1186/bcr315 (Pubitemid 32851163)
46. JE Klaunig LM Kamendulis 2004 The role of oxidative stress in carcinogenesis Annual Review of Pharmacology and Toxicology 44 239 267 1:CAS:528:DC%2BD2cXhvVCktL8%3D 14744246 10.1146/annurev.pharmtox.44.101802. 121851 (Pubitemid 38263841)
47. F Tas H Hansel A Belce, et al. 2005 Oxidative stress in breast cancer Medical Oncology 22 11 15 1:CAS:528:DC%2BD2MXltFSjur0%3D 15750191 10.1385/MO:22:1:011
48. DH Kang 2002 Oxidative stress, DNA damage and breast cancer AACN Clinical Issues 13 540 549 12473916 10.1097/00044067-200211000-00007
49. SC Sikka 2003 Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention-a mechanistic approach Current Medicinal Chemistry 10 2679 2692 1:CAS:528:DC%2BD3sXpt1Kms7c%3D 14529458 10.2174/0929867033456341 (Pubitemid 37456038)
50. A Aydin Z Arsova-Sarafinovska A Sayal, et al. 2006 Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostate hyperplasia Clinical Biochemistry 39 176 179 1:CAS:528:DC%2BD28XhsF2hsLk%3D 16413012 10.1016/j.clinbiochem.2005.11.018 (Pubitemid 43255508)
51. T Otamiri R Sjodahl 1989 Increased lipid peroxidation in malignant tissues of patients with colorectal cancer Cancer 64 422 425 1:STN:280:DyaL1M3osl2ksQ%3D%3D 2544250 10.1002/1097-0142(19890715)64:2<422:: AID-CNCR2820640214>3.0.CO;2-2
52. G Oxdemirler H Pabucçoglu T Bulut, et al. 1989 Increased lipoperoxide levels and antioxidant system in colorectal cancer Journal of Cancer Research and Clinical Oncology 124 555 559
53. NR Asal DR Risser S Kadamani, et al. 1990 Risk factors in renal cell carcinoma. I. Methodology, demographics, tobacco beverage use and obesity Cancer Detection and Prevention 11 359 377
54. M Gago-Dominguez JE Castelao JM Yuan, et al. 2002 Lipid peroxidation: A novel and unifying concept of the etiology of renal cell carcinoma Cancer Causes & Control 13 287 293 10.1023/A:1015044518505 (Pubitemid 34438239)
55. S Manoharan K Kolanjiappan K Suresh, et al. 2005 Lipid peroxidation and antioxidants status in patients with oral squamous cell carcinoma The Indian Journal of Medical Research 122 529 534 1:CAS:528:DC%2BD28Xjs1Kjurg%3D 16518005
56. DN Seril J Liao GY Yang, et al. 2003 Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models Carcinogenesis 34 353 362 10.1093/carcin/24.3.353 (Pubitemid 36432628)
57. K Batcioglu N Mehmet IC Ozturk, et al. 2006 Lipid peroxidation and antioxidant status in stomach cancer Cancer Investigation 24 18 21 1:CAS:528:DC%2BD28XhsVSmtbY%3D 16466987 10.1080/07357900500449603 (Pubitemid 43247268)
58. P Jaruga TH Zastawny J Skokowski, et al. 1992 Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer FEBS Letters 341 59 64 10.1016/0014-5793(94)80240-8
59. KA Conklin 2004 Chemotherapy-associated oxidative stress: Impact on chemotherapeutic effectiveness Integrated Cancer Therapies 3 294 300 1:CAS:528:DC%2BD2cXhtFSjur7F 10.1177/1534735404270335 (Pubitemid 39552423)
60. GL Nicolson KA Conklin 2008 Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy Clinical & Experimental Metastasis 25 161 169 1:CAS:528:DC%2BD1cXmtFyhtbc%3D 10.1007/s10585-007-9129-z
61. KA Conklin 2000 Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects Nutrition and Cancer 37 1 18 1:CAS:528:DC%2BD3cXmtFOms7g%3D 10965514 10.1207/S15327914NC37011
62. DJ Betteridge 2000 What is oxidative stress? Metabolism 49 suppl 1 3 8 1:CAS:528:DC%2BD3cXht1yhsbs%3D 10693912 10.1016/S0026-0495(00)80077-3
63. S Hauptlorenz H Esterbauer W Moll, et al. 1985 Effects of the lipid peroxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells Biochemical Pharmacology 34 3803 3809 1:CAS:528:DyaL28XmtFKjug%3D%3D 3840691 10.1016/0006-2952(85)90428-9 (Pubitemid 16195447)
64. MJ Gonzalez 1992 Lipid peroxidation and tumor growth: An inverse relationship Medical Hypotheses 38 106 110 1:STN:280:DyaK38vgvVGnug%3D%3D 1528153 10.1016/0306-9877(92)90081-M
65. RE Schackelford WK Kaufmann RS Paules 2000 Oxidative stress and cell cycle checkpoint function Free Radical Biology & Medicine 28 1387 1404 10.1016/S0891-5849(00)00224-0 (Pubitemid 30621482)
66. AK Balin DBP Goodman H Rasmussen, et al. 1978 Oxygen-sensitive stages of the cell cycle of human diploid cells The Journal of Cell Biology 78 390 400 1:CAS:528:DyaE1cXlsFymt7k%3D 690172 10.1083/jcb.78.2.390
67. S Kurata 2000 Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress The Journal of Biological Chemistry 275 23413 23416 1:CAS:528:DC%2BD3cXls12mtr8%3D 10856288 10.1074/jbc.C000308200 (Pubitemid 30624618)
68. Q Wei ML Frazier B Levin 2000 DNA repair: A double edge sword Journal of the National Cancer Institute 92 440 441 1:STN:280:DC%2BD3c7otlOlsg%3D%3D 10716953 10.1093/jnci/92.6.440
69. T Fojo 2001 Cancer, DNA repair mechanisms, and resistance to chemotherapy Journal of the National Cancer Institute 93 1434 1436 1:CAS:528: DC%2BD3MXnvVClsrg%3D 11584051 10.1093/jnci/93.19.1434
70. W Zhen CJ Link PM O'Connor, et al. 1992 Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines Molecular and Cellular Biology 12 3689 3698 1:CAS:528: DyaK38Xls1enurs%3D 1380646
71. Y-J Lee E Shacter 1999 Oxidative stress inhibits apoptosis in human lymphoma cells The Journal of Biological Chemistry 274 19792 19798 1:CAS:528:DyaK1MXksFKmtb0%3D 10391922 10.1074/jbc.274.28.19792 (Pubitemid 29327760)
72. E Shacter JA Williams RM Hinson, et al. 2000 Oxidative stress interferes with cancer chemotherapy: Inhibition of lymphoma cell apoptosis and phagocytosis Blood 96 307 313 1:CAS:528:DC%2BD3cXksVKjt7k%3D 10891466
73. MB Hampton B Fadeel S Orrenius 1998 Redox regulation of the caspases during apoptosis Annals of the New York Academy of Sciences 854 328 335 1:CAS:528:DyaK1MXjtVehsg%3D%3D 9928441 10.1111/j.1749-6632.1998.tb09913.x (Pubitemid 29022813)
74. J Chandra A Samali S Orrenius 2000 Triggering and modulation of apoptosis by oxidative stress Free Radical Biology & Medicine 29 323 333 1:CAS:528:DC%2BD3cXnslWmt7s%3D 10.1016/S0891-5849(00)00302-6
75. JS Greenberger VE Kagan L Pearce, et al. 2001 Modulation of redox signal transduction pathways in the treatment of cancer Antioxidants Redox Signaling 3 347 359 1:CAS:528:DC%2BD3MXlt1Ghsrs%3D 11491649 10.1089/15230860152409004
76. LE Feinendegen M Pollycove RD Neumann 2007 Whole-body responses to low-level radiation exposure: New concepts in mammalian radiobiology Experimental Hematology 35 37 46 1:CAS:528:DC%2BD2sXjsVeks70%3D 17379086 10.1016/j.exphem.2007.01.011 (Pubitemid 46427981)
77. MW Epperly JE Gretton CA Sikora, et al. 2003 Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage Radiation Research 160 568 578 1:CAS:528:DC%2BD3sXos1Ggtr0%3D 14565825 10.1667/RR3081 (Pubitemid 38055205)
78. I Sabbarova A Kanai 2007 Targeted delivery of radioprotective agents to mitochondria Molecular Interventions 8 295 302
79. JK Leach SM Black RK Schmidt-Ullrich RB Mikkelsen 2002 Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation The Journal of Biological Chemistry 277 15400 15406 1:CAS:528:DC%2BD38Xjs1Squr4%3D 11856735 10.1074/jbc.M110309200 (Pubitemid 34967802)
80. 10 for prevention of anthracycline-induced cardiotoxicity Integrated Cancer Therapies 4 110 130 1:CAS:528:DC%2BD2MXlsFaht7k%3D 10.1177/1534735405276191 (Pubitemid 40731561)
81. AL Lehninger 1951 Phosphorylation coupled to oxidation of dihydrodiphosphopyridine nucleotide The Journal of Biological Chemistry 190 345 359 1:CAS:528:DyaG3MXksVGnsg%3D%3D 14841183
82. UF Rasmussen HN Rasmussen 1985 The NADH oxidase system (external) of muscle mitochondria and its role in the oxidation of cytoplasmic NADH The Biochemical Journal 229 632 641
83. H Nohl 1987 Demonstration of the existence of an organo-specific NADH dehydrogenase in heart mitochondria European Journal of Biochemistry 169 585 591 1:CAS:528:DyaL1cXhvValug%3D%3D 3691507 10.1111/j.1432-1033.1987.tb13649.x
84. KJA Davies JH Doroshow 1986 Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase Journal of Biological Chemistry 261 3060 3067 1:CAS:528:DyaL28XhsVWrtbw%3D 3456345
85. JH Doroshow KJA Davies 1986 Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical The Journal of Biological Chemistry 261 3068 3074 1:CAS:528: DyaL28XhsVWrtb0%3D 3005279
86. L Gille H Nohl 1997 Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity Free Radical Biology & Medicine 23 775 782 1:CAS:528:DyaK2sXls1ylurg%3D 10.1016/S0891-5849(97)00025-7 (Pubitemid 27364872)
87. 10 in children and adolescents undergoing doxorubicin therapy Clinica Chimica Acta 302 1 9 1:CAS:528:DC%2BD3cXnvVamsbg%3D 10.1016/S0009-8981(00)00316-8
88. 10) in man. In K. Folkers & Y. Yamamura (Eds.), Biomedical and clinical aspects of coenzyme Q (Vol. 5, pp. 241-245). Amsterdam: Elsevier.
89. LC Papadopoulou AS Tsiftsoglou 1996 Effects of hemin on apoptosis, suppression of cytochrome C oxidase gene expression, and bone-marrow toxicity induced by doxorubicin Biochemical Pharmacology 52 713 722 1:CAS:528: DyaK28XltFOrs7g%3D 8765469 10.1016/0006-2952(96)00349-8 (Pubitemid 26276487)
90. CM Palmeira J Serrano DW Kuehl, et al. 1997 Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin Biochimica et Biophysica Acta 1321 101 106 1:CAS:528:DyaK2sXlsFGnt78%3D 9332499 10.1016/S0005-2728(97)00055-8 (Pubitemid 27390500)
91. DM Brizel 2007 Pharmacologic approaches to radiation protection Journal of Clinical Oncology 25 4084 4089 1:CAS:528:DC%2BD2sXhtlKqsbrP 17827457 10.1200/JCO.2007.11.5816 (Pubitemid 47492952)
92. 10 Cancer Treatment Reports 65 79 91 1:CAS:528:DyaL3MXhvVGmtbg%3D 7226168
93. 10 Toxicology Letters 12 75 82 1:CAS:528:DyaL38XkvVCrur0%3D 7112605 10.1016/0378-4274(82)90201-6 (Pubitemid 12012009)
94. 10 reduction of adriamycin cardiotoxicity. In K. Folkers & Y. Yamamura (Eds.), Biomedical and clinical aspects of coenzyme Q (Vol. 4, pp. 231-241). Amsterdam: North-Holland Biomedical.
95. 10 Cancer Treatment Reports 62 887 891 1:CAS:528:DyaE1cXltVShtLw%3D 667863
96. R Buckingham J Fitt J Sitzia 1997 Patients' experience of chemotherapy: Side-effects of carboplatin in the treatment of carcinoma of the ovary European Journal of Cancer Care 6 59 71 1:STN:280:DyaK2szotFOnsg%3D%3D 9238931 10.1111/j.1365-2354.1997.tb00270.x
97. 10 on anthracyclines cardiotoxicity: Control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma Molecular Aspects of Medicine 15 S207 S212 7752832 10.1016/0098-2997(94)90030-2
98. YK Loke D Price S Derry, et al. 2006 Case reports of suspected adverse drug reactions-systematic literature survey of follow-up British Medical Journal 232 335 339 10.1136/bmj.38701.399942.63 (Pubitemid 43253749)
99. JH Von Roenn JA Paice 2005 Control of common, non-pain cancer symptoms Seminars in Oncology 32 200 210 10.1053/j.seminoncol.2004.11.019 (Pubitemid 40463296)
100. T Borneman BF Piper VC Sun, et al. 2007 Implementing the fatigue guidelines at one NCCN member institution: Process and outcomes Journal of the National Comprehensive Cancer Network 5 1092 1101 18053431
101. CP Escalante MA Kallen RU Valdres, et al. 2010 Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center Journal of Pain and Symptom Management 39 691 701 20226622 10.1016/j.jpainsymman.2009.09.010
102. JL Ryan JK Carroll EP Ryan, et al. 2007 Mechanisms of cancer-related fatigue The Oncologist 12 Suppl. 1 22 34 1:CAS:528:DC%2BD2sXotFagtL0%3D 17573453 10.1634/theoncologist.12-S1-22
103. KM Mustian GR Morrow JK Carroll, et al. 2007 Integrative nonpharmacological behavioral interventions for the management of cancer-related fatigue The Oncologist 12 Suppl. 1 52 67 17573456 10.1634/theoncologist.12-S1- 52
104. T Watson V Mock 2004 Exercise as an intervention for cancer-related fatigue Physical Therapy 84 736 743 15283624
105. PC Zee S Acoli-Isreal 2009 Does effective management of sleep disorders reduce cancer-related fatigue? Drugs 69 Suppl. 2 29 41 1:CAS:528: DC%2BC3cXitFCqsbk%3D 20047349 10.2165/11531140-000000000-00000
106. O Milton A Richardson M Sharpe, et al. 2008 A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue Journal of the National Cancer Institute 100 1 12
107. M Levy 2008 Cancer fatigue: A review for psychiatrists General Hospital Psychiatry 30 233 244 18433655 10.1016/j.genhosppsych.2008.01.004 (Pubitemid 351538964)
108. GL Nicolson 2003 Lipid replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function Journal of the American Nutraceutical Association 6 3 22 28
109. M Agadjanyan V Vasilevko A Ghochikyan, et al. 2003 Nutritional supplement (NTFactor) restores mitochondrial function and reduces moderately severe fatigue in aged subjects Journal of Chronic Fatigue Syndrome 11 3 23 26 10.1300/J092v11n0303
110. GL Nicolson 2005 Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function Pathology Oncology Research 11 139 144 1:CAS:528:DC%2BD2MXht1agu7fL 16195767 10.1007/BF02893390
111. YH Wei HC Lee 2002 Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging Experimental Biology and Medicine 227 671 682 1:CAS:528:DC%2BD38XntlyqsLw%3D 12324649
112. H Huang KG Manton 2004 The role of oxidative damage in mitochondria during aging: A review Frontiers in Bioscience 9 1100 1117 1:CAS:528: DC%2BD2cXhtFCqu78%3D 14977532 10.2741/1298
113. AC Logan C Wong 2001 Chronic fatigue syndrome: Oxidative stress and dietary modifications Alternative Medicine Review 6 450 459 1:STN:280: DC%2BD3MnltF2msg%3D%3D 11703165
114. y Manuel B Keenoy G Moorkens J Vertommen I De Leeuw 2001 Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome Life Science 68 2037 2049 10.1016/S0024-3205(01)01001-3 (Pubitemid 32245604)
115. RS Richards TK Roberts NR McGregor, et al. 2000 Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome Redox Reports 5 35 41 1:CAS:528:DC%2BD3cXltlKrs74%3D
116. S Felle P Mecocci G Fano, et al. 2000 Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome Free Radical Biology & Medicine 29 1252 1259 10.1016/S0891-5849(00) 00419-6
117. MU Dianzani 1993 Lipid peroxidation and cancer Critical Reviews in Oncology/Hematology 15 125 147 1:STN:280:DyaK2c7mtFyltA%3D%3D 8117415 10.1016/1040-8428(93)90052-6 (Pubitemid 24013566)
118. ML Pall 2000 Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome Medical Hypotheses 54 115 125 1:CAS:528: DC%2BD3cXis1SitL0%3D 10790736 10.1054/mehy.1998.0825 (Pubitemid 30156647)
119. GL Nicolson G Poste T Ji 1977 Dynamic aspects of cell membrane organization Cell Surface Reviews 3 1 73 1:CAS:528:DyaE1cXntVGhtQ%3D%3D
120. WK Subczynski A Wisniewska 2000 Physical properties of lipid bilayer membranes: Relevance to membrane biological functions Acta Biochimica Polonica 47 613 625 1:CAS:528:DC%2BD3cXotV2jtLw%3D 11310964
121. R Radi M Rodriguez L Castro, et al. 1994 Inhibition of mitochondrial electronic transport by peroxynitrite Archives of Biochemistry and Biophysics 308 89 95 1:STN:280:DyaK2c7ksFWisg%3D%3D 8311480 10.1006/abbi.1994.1013 (Pubitemid 24172608)
122. T Kanno EE Sato S Muranaka, et al. 2004 Oxidative stress underlies the mechanism for Ca(2+)-induced permeability transition of mitochondria Free Radical Research 38 27 35 1:CAS:528:DC%2BD2cXhsVSmtb4%3D 15061651 10.1080/10715760310001626266 (Pubitemid 38128512)
123. GL Nicolson R Ellithrope 2006 Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses Journal of Chronic Fatigue Syndrome 13 1 57 68 10.1300/J092v13n0106
124. RR Ellithorpe R Settineri GL Nicolson 2003 Reduction of fatigue by use of a dietary supplement containing glycophospholipids Journal of the American Nutraceutical Association 6 1 23 28
125. CM Mansbach R Dowell 2000 Effect of increasing lipid loads on the ability of the endoplasmic reticulum to transport lipid to the Golgi Journal of Lipid Research 41 605 612 1:CAS:528:DC%2BD3cXjt1ChtrY%3D 10744781
126. M Seidman MJ Khan WX Tang, et al. 2002 Influence of lecithin on mitochondrial DNA and age-related hearing loss Otolaryngology - Head and Neck Surgery 127 138 144 12297801 10.1067/mhn.2002.127627
127. BF Piper AM Linsey MJ Dodd 1987 Fatigue mechanism in cancer Oncology Nursing Forum 14 17 23 1:STN:280:DyaL1c%2Fps1yhsw%3D%3D 3320981
128. GL Nicolson RR Ellithorpe C Ayson-Mitchell, et al. 2010 Lipid replacement therapy with a glycophospholipid-antioxidant-vitamin formulation significantly reduces fatigue within one week Journal of the American Nutraceutical Association 13 1 11 15
129. L Colodny K Lynch C Farber, et al. 2000 Results of a study to evaluate the use of Propax to reduce adverse effects of chemotherapy Journal of the American Nutraceutical Association 2 1 17 25